Cargando…

Targeting histone deacetylase-3 blocked epithelial-mesenchymal plasticity and metastatic dissemination in gastric cancer

BACKGROUND AND PURPOSE: Histone deacetylase (HDAC) inhibitors (HDIs) can modulate the epithelial-mesenchymal transition (EMT) progression and inhibit the migration and invasion of cancer cells. Emerging as a novel class of anti-cancer drugs, HDIs are attracted much attention in the field of drug dis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Sheng-Mao, Jan, Yee-Jee, Tsai, Shih-Chuan, Pan, Hung-Chuan, Shen, Chin-Chang, Yang, Cheng-Ning, Lee, Shu-Hua, Liu, Shing-Hwa, Shen, Li-Wei, Chiu, Chien-Shan, Arbiser, Jack L., Meng, Menghsiao, Sheu, Meei-Ling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547655/ https://www.ncbi.nlm.nih.gov/pubmed/34973135 http://dx.doi.org/10.1007/s10565-021-09673-2

Ejemplares similares

The novel Aryl hydrocarbon receptor inhibitor biseugenol inhibits gastric tumor growth and peritoneal dissemination
por: Lai, De-Wei, et al.
Publicado: (2014)

Calpain/SHP-1 Interaction by Honokiol Dampening Peritoneal Dissemination of Gastric Cancer in nu/nu Mice
por: Liu, Shing Hwa, et al.
Publicado: (2012)

Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
por: Phimmachanh, Monica, et al.
Publicado: (2020)

Histone deacetylase activity mediates thermal plasticity in zebrafish (Danio rerio)
por: Seebacher, Frank, et al.
Publicado: (2019)

Histone Deacetylases and Their Regulatory MicroRNAs in Hepatocarcinogenesis
por: Kim, Hyung Seok, et al.
Publicado: (2015)

Beyond Histone and Deacetylase: An Overview of Cytoplasmic Histone Deacetylases and Their Nonhistone Substrates
por: Yao, Ya-Li, et al.
Publicado: (2011)

Tetrahydroisoquinolines as novel histone deacetylase inhibitors for treatment of cancer
por: Chen, Danqi, et al.
Publicado: (2016)

Snail regulation in fibroblast-like synoviocytes by a histone deacetylase or glycogen synthase kinase inhibitor affects cell proliferation and gene expression
por: Shen, Po-Chuan, et al.
Publicado: (2021)

Histone deacetylase inhibition facilitates massed pattern-induced synaptic plasticity and memory
por: Pandey, Kiran, et al.
Publicado: (2015)

Histone Deacetylases and Histone Deacetylase Inhibitors: Molecular Mechanisms of Action in Various Cancers
por: Sanaei, Masumeh, et al.
Publicado: (2019)

Histone Acetylation Level and Histone Acetyltransferase/Deacetylase Activity in Ejaculated Sperm from Normozoospermic Men
por: Kim, Jee Hyun, et al.
Publicado: (2014)

Histone deacetylase inhibitors blocked activation and caused senescence of corneal stromal cells
por: Zhou, Qingjun, et al.
Publicado: (2008)

The histone deacetylase SIRT6 blocks myostatin expression and development of muscle atrophy
por: Samant, Sadhana A., et al.
Publicado: (2017)

New Aspects of Vascular Calcification: Histone Deacetylases and Beyond
por: Kwon, Duk-Hwa, et al.
Publicado: (2017)

Histone deacetylase HDA-1 modulates mitochondrial stress response and longevity
por: Shao, Li-Wa, et al.
Publicado: (2020)

Deletion of the gene encoding the reductase component of 3-ketosteroid 9α-hydroxylase in Rhodococcus equi USA-18 disrupts sterol catabolism, leading to the accumulation of 3-oxo-23,24-bisnorchola-1,4-dien-22-oic acid and 1,4-androstadiene-3,17-dione
por: Yeh, Chin-Hsing, et al.
Publicado: (2014)

Effect of 3-subsitution of quinolinehydroxamic acids on selectivity of histone deacetylase isoforms
por: Mehndiratta, Samir, et al.
Publicado: (2020)

Chemical Phylogenetics of Histone Deacetylases
por: Bradner, James E., et al.
Publicado: (2010)

Histone deacetylases in viral infections
por: Herbein, Georges, et al.
Publicado: (2010)

Butyrate Histone Deacetylase Inhibitors
por: Steliou, Kosta, et al.
Publicado: (2012)

Histone deacetylase signaling in cardioprotection
por: Lehmann, Lorenz H., et al.
Publicado: (2013)

Histone deacetylase 6 in cancer
por: Li, Ting, et al.
Publicado: (2018)

Histone deacetylase inhibitors modulate metalloproteinase gene expression in chondrocytes and block cartilage resorption
por: Young, David A, et al.
Publicado: (2005)

Blocking autophagy overcomes resistance to dual histone deacetylase and proteasome inhibition in gynecologic cancer
por: Bi, Jianling, et al.
Publicado: (2022)

Histone deacetylase inhibitors suppress mutant p53 transcription via histone deacetylase 8
por: Yan, Wensheng, et al.
Publicado: (2012)

Histone deacetylase 9 regulates breast cancer cell proliferation and the response to histone deacetylase inhibitors
por: Lapierre, Marion, et al.
Publicado: (2016)

Comprehensive analysis of histone deacetylases genes in the prognosis and immune infiltration of glioma patients
por: Shen, Lin, et al.
Publicado: (2022)

Histone Deacetylases in Neural Stem Cells and Induced Pluripotent Stem Cells
por: Sun, Guoqiang, et al.
Publicado: (2011)

The role of class IIa histone deacetylases in regulating endothelial function
por: Shen, Zexu, et al.
Publicado: (2023)

Genome-scale network model of metabolism and histone acetylation reveals metabolic dependencies of histone deacetylase inhibitors
por: Shen, Fangzhou, et al.
Publicado: (2019)

Histone deacetylase 3, not histone deacetylase 2, interacts with the major immediate early locus of human cytomegalovirus
por: Huang, Ying, et al.
Publicado: (2011)

Histone deacetylase enzymes and selective histone deacetylase inhibitors for antitumor effects and enhancement of antitumor immunity in glioblastoma
por: Yelton, Caleb J., et al.
Publicado: (2018)

Inhibition of histone deacetylases attenuates tumor progression and improves immunotherapy in breast cancer
por: Lian, Bi, et al.
Publicado: (2023)

Honokiol Induces Calpain-Mediated Glucose-Regulated Protein-94 Cleavage and Apoptosis in Human Gastric Cancer Cells and Reduces Tumor Growth
por: Sheu, Meei Ling, et al.
Publicado: (2007)

Histone deacetylase 10 structure and molecular function as a polyamine deacetylase
por: Hai, Yang, et al.
Publicado: (2017)

2-O-Methylmagnolol, a Magnolol Derivative, Suppresses Hepatocellular Carcinoma Progression via Inhibiting Class I Histone Deacetylase Expression
por: Chen, Chi-Yuan, et al.
Publicado: (2020)

Histone deacetylase inhibitors in multiple myeloma
por: Deleu, Sarah, et al.
Publicado: (2009)

Histone deacetylases in RA: epigenetics and epiphenomena
por: Grabiec, Aleksander M, et al.
Publicado: (2010)

Histone deacetylase inhibitors in Hodgkin lymphoma
por: Buglio, Daniela, et al.
Publicado: (2010)

Clinical Toxicities of Histone Deacetylase Inhibitors
por: Subramanian, Srividya, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_6gequo9hshhb7bifs2ihrek4ii